Cargando…

Small cell carcinoma of the prostate after low-dose-rate brachytherapy: a case report

BACKGROUND: Small cell carcinoma of the prostate is a rare condition with important differences from prostatic adenocarcinoma in terms of clinical and prognostic characteristics. A low prostate-specific antigen and a symptomatic patient, including paraneoplastic symptoms, characterize small cell car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Bos, Eva, Dekuyper, Peter, Gabriel, Charlotte, Waterloos, Marjan, Van Baelen, Anthony, Huybrechts, Stefan, Ameye, Filip, Lambrecht, Antoon, Vulsteke, Christof, Soenens, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592557/ https://www.ncbi.nlm.nih.gov/pubmed/33109264 http://dx.doi.org/10.1186/s13256-020-02523-5

Ejemplares similares

Low dose rate prostate brachytherapy
por: Stish, Bradley J., et al.
Publicado: (2018)

Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Maenhout, Metha, et al.
Publicado: (2017)

High dose-rate brachytherapy in the treatment of prostate cancer
por: Mendez, Lucas C., et al.
Publicado: (2018)

Bi‐objective optimization of catheter positions for high‐dose‐rate prostate brachytherapy
por: van der Meer, Marjolein C., et al.
Publicado: (2020)

Focal low-dose rate brachytherapy for the treatment of prostate cancer
por: Tong, William Y, et al.
Publicado: (2013)

Sensitivity of dose‐volume indices to computation settings in high‐dose‐rate prostate brachytherapy treatment plan evaluation
por: van der Meer, Marjolein C., et al.
Publicado: (2019)

Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer
por: Maenhout, Metha, et al.
Publicado: (2017)

Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options
por: Skowronek, Janusz
Publicado: (2013)

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
por: Barnes, Justin, et al.
Publicado: (2019)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

High-dose-rate brachytherapy boost for prostate cancer: rationale and technique
por: Morton, Gerard C.
Publicado: (2014)

A novel perineal shield for low-dose-rate prostate brachytherapy
por: Weiner, Joseph P., et al.
Publicado: (2015)

Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer
por: Van Son, Marieke J, et al.
Publicado: (2018)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
por: Hathout, Lara, et al.
Publicado: (2019)

Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature
por: Kunogi, Hiroaki, et al.
Publicado: (2016)

Dose Distribution of High Dose-Rate and Low Dose-Rate Prostate Brachytherapy at Different Intervals—Impact of a Hydrogel Spacer and Prostate Volume
por: Haddad, Hathal, et al.
Publicado: (2023)

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013)

Pulmonary Metastases After Low-Dose-Rate Brachytherapy for Localized Prostate Cancer
por: Kido, Masahito, et al.
Publicado: (2014)

High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective
por: Yoshioka, Yasuo, et al.
Publicado: (2014)

Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer
por: Contreras, Jessika A., et al.
Publicado: (2015)

Advantages of TRUS-based delineation for high-dose-rate prostate brachytherapy planning
por: Lavoie-Gagnon, Heloise, et al.
Publicado: (2022)

Control charts for evaluation of quality of low-dose-rate brachytherapy for prostate cancer
por: Nasser, Nicola J., et al.
Publicado: (2022)

The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer
por: Tanaka, Nobumichi
Publicado: (2023)

Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
por: Slevin, Finbar, et al.
Publicado: (2020)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot
por: Keam, Simon P, et al.
Publicado: (2020)

Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients
por: van Son, Marieke, et al.
Publicado: (2020)

Evaluation of the dosimetric impact of loss and displacement of seeds in prostate low-dose-rate brachytherapy
por: Wang, Yinkun, et al.
Publicado: (2015)

The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy
por: Echevarria, Michelle I., et al.
Publicado: (2016)

Evaluation of the MIM Symphony treatment planning system for low‐dose‐rate‐ prostate brachytherapy
por: Dhanesar, Sandeep K., et al.
Publicado: (2015)

Focal application of low-dose-rate brachytherapy for prostate cancer: a pilot study
por: Mahdavi, S. Sara, et al.
Publicado: (2017)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
por: Ma, Ting Martin, et al.
Publicado: (2020)

Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer
por: Olsén, Johan Staby, et al.
Publicado: (2022)

High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome
por: Strouthos, Iosif, et al.
Publicado: (2021)

An audit of high dose-rate prostate brachytherapy treatment planning at six Swedish clinics
por: Dohlmar, Frida, et al.
Publicado: (2021)

Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate Cancer
por: Kato, Manabu, et al.
Publicado: (2023)

Dose differentiated high-dose-rate prostate brachytherapy: a feasibility assessment of MRI-guided dose escalation to dominant intra-prostatic lesions
por: Luminais, Christopher K., et al.
Publicado: (2022)

Salvage high-dose-rate brachytherapy for prostate cancer persistence after brachytherapy: repeated use of a polyethylene glycol hydrogel spacer
por: Hepp, Rodrigo, et al.
Publicado: (2018)

Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy
por: Hackett, Cian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2mg47ma29g1b5qcsnf2786va1o